BLACKROCK CORE BOND TRUST (BHK)

US09249E1010

10.59  +0.01 (+0.09%)

After market: 10.55 -0.04 (-0.38%)

Fundamental Rating

2

BHK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of BHK have multiple concerns. BHK has a expensive valuation and it also scores bad on growth.



Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BHK was profitable.
In the past year BHK had a positive cash flow from operations.
BHK had positive earnings in 4 of the past 5 years.
BHK had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

The 3 year average ROIC (2.64%) for BHK is below the current ROIC(2.68%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.87%
ROE 9.29%
ROIC 2.68%
ROA(3y)-4.45%
ROA(5y)1.39%
ROE(3y)-8.26%
ROE(5y)0.56%
ROIC(3y)2.64%
ROIC(5y)2.58%

1.3 Margins

BHK's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of BHK has declined.
BHK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 58.61%
PM (TTM) 106.22%
GM 59.6%
OM growth 3Y-11.07%
OM growth 5Y-4.99%
PM growth 3Y-22.32%
PM growth 5YN/A
GM growth 3Y-11.09%
GM growth 5Y-4.95%

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for BHK remains at a similar level compared to 1 year ago.
BHK has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BHK has an improved debt to assets ratio.

2.2 Solvency

BHK has an Altman-Z score of 0.53. This is a bad value and indicates that BHK is not financially healthy and even has some risk of bankruptcy.
BHK has a debt to FCF ratio of 2.23. This is a good value and a sign of high solvency as BHK would need 2.23 years to pay back of all of its debts.
A Debt/Equity ratio of 0.51 indicates that BHK is somewhat dependend on debt financing.
Even though the debt/equity ratio score it not favorable for BHK, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 2.23
Altman-Z 0.53
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

BHK has a Current Ratio of 0.05. This is a bad value and indicates that BHK is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.05 indicates that BHK may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05

More info and screens

3

3. Growth

3.1 Past

BHK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 127.20%, which is quite impressive.
The earnings per share for BHK have been decreasing by -19.34% on average. This is quite bad
Looking at the last year, BHK shows a quite strong growth in Revenue. The Revenue has grown by 8.95% in the last year.
BHK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.26% yearly.
EPS 1Y (TTM)127.2%
EPS 3Y-19.34%
EPS 5YN/A
EPS Q2Q%201.15%
Revenue 1Y (TTM)8.95%
Revenue growth 3Y3.89%
Revenue growth 5Y0.26%
Sales Q2Q%5.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BHK is valuated reasonably with a Price/Earnings ratio of 10.38.
Compared to an average S&P500 Price/Earnings ratio of 27.54, BHK is valued rather cheaply.
Industry RankSector Rank
PE 10.38
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF 4.23
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.77%, BHK is a good candidate for dividend investing.
BHK's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 7.77%

5.2 History

The dividend of BHK has a limited annual growth rate of 2.78%.
BHK has paid a dividend for at least 10 years, which is a reliable track record.
BHK has decreased its dividend recently.
Dividend Growth(5Y)2.78%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

87.49% of the earnings are spent on dividend by BHK. This is not a sustainable payout ratio.
DP87.49%
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

BLACKROCK CORE BOND TRUST

NYSE:BHK (12/24/2024, 7:57:59 PM)

After market: 10.55 -0.04 (-0.38%)

10.59

+0.01 (+0.09%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners21.01%
Inst Owner Change3.71%
Ins OwnersN/A
Ins Owner Change0.17%
Market Cap572.50M
Analysts45
Price TargetN/A
Short Float %1.16%
Short Ratio5.02
Dividend
Industry RankSector Rank
Dividend Yield 7.77%
Dividend Growth(5Y)2.78%
DP87.49%
Div Incr Years1
Div Non Decr Years1
Ex-Date12-16 2024-12-16 (0.0746)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.38
Fwd PE N/A
P/S 11
P/FCF 4.23
P/OCF 4.23
P/B 0.96
P/tB 0.96
EV/EBITDA N/A
EPS(TTM)1.02
EY9.63%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.5
FCFY23.62%
OCF(TTM)2.5
OCFY23.62%
SpS0.96
BVpS11.01
TBVpS11.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.87%
ROE 9.29%
ROCE 5.11%
ROIC 2.68%
ROICexc 2.69%
ROICexgc 2.71%
OM 58.61%
PM (TTM) 106.22%
GM 59.6%
FCFM 259.9%
ROA(3y)-4.45%
ROA(5y)1.39%
ROE(3y)-8.26%
ROE(5y)0.56%
ROIC(3y)2.64%
ROIC(5y)2.58%
ROICexc(3y)2.64%
ROICexc(5y)2.58%
ROICexgc(3y)2.67%
ROICexgc(5y)2.61%
ROCE(3y)5.18%
ROCE(5y)4.77%
ROICexcg growth 3Y1.61%
ROICexcg growth 5Y-1.08%
ROICexc growth 3Y1.76%
ROICexc growth 5Y-1.02%
OM growth 3Y-11.07%
OM growth 5Y-4.99%
PM growth 3Y-22.32%
PM growth 5YN/A
GM growth 3Y-11.09%
GM growth 5Y-4.95%
F-Score7
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 2.23
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.89
Cash Conversion N/A
Profit Quality 244.69%
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z 0.53
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)127.2%
EPS 3Y-19.34%
EPS 5YN/A
EPS Q2Q%201.15%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.95%
Revenue growth 3Y3.89%
Revenue growth 5Y0.26%
Sales Q2Q%5.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.92%
EBIT growth 3Y-7.61%
EBIT growth 5Y-4.74%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y70.3%
FCF growth 3Y84.79%
FCF growth 5Y50.99%
OCF growth 1Y70.3%
OCF growth 3Y84.79%
OCF growth 5Y50.99%